20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Adapthealth Corp (AHCO) operates in the MEDICAL DEVICES industry and is headquartered in Conshohocken, United States with about 10,900 employees. Its market capitalization is roughly $760 million. In the fiscal year ended 2025-12-31, AHCO reported $3.2B in revenue and ($71M) in net income.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Interactive charts & full statements → Open the AHCO valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.0B | $3.2B | $3.3B | $3.2B | $3.0B | $2.5B | $1.1B | $530M | $345M | $193M | $174M |
| Gross Profit | $312M | $569M | $681M | $682M | $417M | $446M | $158M | $89M | $60M | $30M | $16M |
| Gross Margin % | 10.4% | 17.5% | 20.9% | 21.3% | 14.1% | 18.1% | 14.9% | 16.8% | 17.4% | 15.4% | 9.0% |
| Operating Income (EBIT) | ($9M) | $186M | $264M | ($598M) | $190M | $226M | $71M | $29M | ($1M) | $0M | $2M |
| Operating Margin % | -0.3% | 5.7% | 8.1% | -18.7% | 6.4% | 9.2% | 6.8% | 5.5% | -0.4% | -0.0% | 1.3% |
| Net Income | ($228M) | ($71M) | $90M | ($679M) | $69M | $156M | ($162M) | ($21M) | $2M | $0M | ($4M) |
| Net Margin % | -7.6% | -2.2% | 2.8% | -21.2% | 2.3% | 6.4% | -15.3% | -4.0% | 0.6% | -0.0% | -2.2% |
| EBITDA | $290M | $504M | $628M | ($171M) | $631M | $544M | ($82M) | $80M | $7M | $0M | $29M |
| Earnings Per Share (EPS) | $-1.68 | $-0.52 | $0.67 | $-5.05 | $0.50 | $1.17 | $-3.08 | $-0.95 | $0.07 | $-0.00 | $-0.12 |
| Shares Outstanding (M) | 136M | 135M | 136M | 134M | 139M | 133M | 52M | 23M | 31M | 31M | 31M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $740M | $820M | $846M | $603M | $592M | $580M | $857M | $598M |
| Gross Profit | $104M | $101M | $162M | ($56M) | ($54M) | ($77M) | $328M | ($84M) |
| Gross Margin % | 14.1% | 12.4% | 19.2% | -9.2% | -9.1% | -13.3% | 38.3% | -14.1% |
| Operating Income (EBIT) | ($138M) | $7M | $54M | $67M | $79M | $23M | $98M | $63M |
| Operating Margin % | -18.6% | 0.8% | 6.4% | 11.1% | 13.4% | 4.0% | 11.4% | 10.6% |
| Net Income | ($134M) | ($16M) | ($103M) | $25M | $15M | ($7M) | $50M | $23M |
| Net Margin % | -18.1% | -2.0% | -12.1% | 4.1% | 2.5% | -1.2% | 5.9% | 3.8% |
| EBITDA | ($16M) | $123M | $24M | $159M | $156M | $123M | $191M | $154M |
| Earnings Per Share (EPS) | $-0.98 | $-0.12 | $-0.76 | $0.18 | $0.11 | $-0.05 | $0.37 | $0.17 |
| Shares Outstanding (M) | 136M | 136M | 135M | 137M | 137M | 135M | 137M | 137M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $583M | $602M | $542M | $481M | $374M | $276M | $196M | $60M | $68M | $46M | $30M |
| Capital Expenditures (CapEx) | $486M | $382M | $306M | $337M | $391M | $203M | $40M | $21M | $10M | $7M | $2M |
| Free Cash Flow (FCF) | $98M | $219M | $236M | $143M | ($18M) | $72M | $156M | $39M | $58M | $39M | $27M |
| FCF Margin % | 3.2% | 6.8% | 7.2% | 4.5% | -0.6% | 2.9% | 14.8% | 7.4% | 16.9% | 20.3% | 15.8% |
| Dividends Paid | — | — | — | — | — | $4M | $936M | $82M | $250M | $250M | $250M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $145M | $94M | $183M | $161M | $162M | $96M | $150M | $144M |
| Capital Expenditures (CapEx) | $166M | $121M | $104M | $94M | $89M | $96M | $77M | $60M |
| Free Cash Flow (FCF) | ($21M) | ($27M) | $79M | $67M | $73M | $0M | $73M | $85M |
| FCF Margin % | -2.8% | -3.4% | 9.4% | 11.1% | 12.4% | -0.0% | 8.5% | 14.2% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.3B | $4.3B | $4.5B | $4.5B | $5.2B | $5.2B | $1.8B | $228M | $254M | $0M |
| Cash & Cash Equivalents | $43M | $106M | $110M | $77M | $46M | $150M | $100M | $10M | $1M | $0M |
| Total Liabilities | $3.0B | $2.8B | $2.9B | $3.0B | $3.1B | $3.2B | $1.5B | $213M | $9M | $0M |
| Total Debt (Short + Long-Term) | $1.9B | $1.8B | $2.0B | $2.2B | $2.2B | $2.2B | $807M | $397M | $155M | $63M |
| Total Shareholders' Equity | $1.4B | $1.5B | $1.6B | $1.5B | $2.2B | $2.1B | $355M | $15M | $246M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AHCO viewer.
About TickerBase · Data methodology & sources · Privacy · Terms